Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute 
Democratic Senators Push Tougher Russia Energy Sanctions During Ukraine Visit 
Trump Signals Indirect Role in U.S.-Iran Nuclear Talks as Tensions Rise 
Trump Says U.S. Trade Deficit Shrinking Sharply as 2026 Trade Surplus Looms 
Friedrich Merz Signals Strategic China Partnership as EU Pushes Back on U.S. Tariff Policy 
Trump’s Geneva Diplomacy: Iran Nuclear Talks and Russia-Ukraine War Negotiations Raise Concerns 
Tarique Rahman Sworn In as Bangladesh Prime Minister After BNP Election Landslide 
Iran to Submit Nuclear Proposal as U.S. Boosts Military Presence in Middle East 
U.S. Official Alleges China Conducted Underground Nuclear Test at Lop Nor in 2020 
Hezbollah Rejects Lebanon Disarmament Plan as Government Grants Army Four-Month Timeline 
U.S. Official Alleges China Conducted Low-Yield Nuclear Test at Lop Nor in 2020 
How can Europe meet the challenge posed by the retreat of the US? 
Putin Condemns New U.S. Sanctions on Cuba, Pledges Russian Support 
South Korean Court to Deliver Landmark Verdict in Yoon Suk Yeol Insurrection Case 
Peru Congress Ousts President Jose Jeri in ‘Chifagate’ Scandal, Deepening Political Crisis 
Make Japan strong again: Sanae Takaichi’s plan to transform her country’s military 
Xi Jinping Highlights People-to-People Ties as U.S.-China Relations Show Signs of Stabilization 
U.S. National Institutes of Health (NIH) Director Jay Bhattacharya will assume the role of acting director of the Centers for Disease Control and Prevention (CDC), according to a Trump administration official. The appointment marks a major leadership shift within the Department of Health and Human Services (HHS) as the administration prepares for the 2026 midterm elections.
Bhattacharya, a Stanford University professor known for criticizing COVID-19 lockdowns and pandemic restrictions, will now oversee both the NIH and the CDC. The NIH manages a nearly $50 billion budget and funds thousands of medical research projects nationwide, while the CDC leads public health surveillance, disease prevention, and emergency response efforts from its Atlanta headquarters. About two-thirds of the CDC’s budget supports state and local public health agencies.
HHS Deputy Secretary Jim O’Neill, who has served as acting CDC director since August, will step down from both roles as part of the department’s restructuring. He is expected to be offered the position of National Science Foundation director. Bhattacharya’s dual leadership role has raised concerns among former CDC officials, who argue that managing two major federal health agencies simultaneously could weaken the nation’s ability to respond to public health threats.
The CDC has experienced ongoing turmoil, including budget cuts, staffing reductions, and controversy under HHS Secretary Robert F. Kennedy Jr. President Donald Trump previously dismissed CDC Director Susan Monarez after disagreements over vaccine policy changes. Her firing prompted several senior resignations and intensified scrutiny of vaccine guidance decisions, including revisions to childhood immunization recommendations.
Under federal law, Bhattacharya may serve as acting CDC director only until late March unless a permanent nominee is confirmed by the U.S. Senate. Meanwhile, Kennedy announced additional HHS leadership appointments aimed at improving coordination with the White House ahead of the midterm elections, with Republicans expected to focus on healthcare costs, prescription drug pricing, and access to healthy food.
